Hughes Benjamin H, Brinton John T, Ingram David G, Halbower Ann C
School of Medicine, Department of Pediatrics, The University of Colorado Anschutz Medical Campus, Aurora, CO.
The Breathing Institute, Section of Pediatric Pulmonary Medicine, Children's Hospital Colorado, Aurora, CO.
Sleep. 2017 Sep 1;40(9). doi: 10.1093/sleep/zsx120.
Sleep-disordered breathing (SDB) is prevalent among children and is associated with adverse health outcomes. Worldwide, approximately 250 million individuals reside at altitudes higher than 2000 meters above sea level (masl). The effect of chronic high-altitude exposure on children with SDB is unknown. This study aims to determine the impact of altitude on sleep study outcomes in children with SDB dwelling at high altitude.
A single-center crossover study was performed to compare results of high-altitude home polysomnography (H-PSG) with lower altitude laboratory polysomnography (L-PSG) in school-age children dwelling at high altitude with symptoms consistent with SDB. The primary outcome was apnea-hypopnea index (AHI), with secondary outcomes including obstructive AHI; central AHI; and measures of oxygenation, sleep quality, and pulse rate.
Twelve participants were enrolled, with 10 included in the final analysis. Median altitude was 1644 masl on L-PSG and 2531 masl on H-PSG. Median AHI was 2.40 on L-PSG and 10.95 on H-PSG. Both obstructive and central respiratory events accounted for the difference in AHI. Oxygenation and sleep fragmentation were worse and pulse rate higher on H-PSG compared to L-PSG.
These findings reveal a clinically substantial impact of altitude on respiratory, sleep, and cardiovascular outcomes in children with SDB who dwell at high altitude. Within this population, L-PSG underestimates obstructive sleep apnea and central sleep apnea compared to H-PSG. Given the shortage of high-altitude pediatric sleep laboratories, these results suggest a role for home sleep apnea testing for children residing at high altitude.
睡眠呼吸障碍(SDB)在儿童中很普遍,且与不良健康后果相关。在全球范围内,约有2.5亿人居住在海拔高于海平面2000米(masl)的地区。慢性高海拔暴露对患有SDB的儿童的影响尚不清楚。本研究旨在确定海拔高度对居住在高海拔地区的SDB儿童睡眠研究结果的影响。
进行了一项单中心交叉研究,以比较居住在高海拔地区且有SDB症状的学龄儿童的高海拔家庭多导睡眠图(H-PSG)结果与低海拔实验室多导睡眠图(L-PSG)结果。主要结果是呼吸暂停低通气指数(AHI),次要结果包括阻塞性AHI;中枢性AHI;以及氧合、睡眠质量和脉搏率的测量值。
招募了12名参与者,最终分析纳入了10名。L-PSG时的海拔中位数为1644 masl,H-PSG时为2531 masl。L-PSG时的AHI中位数为2.40,H-PSG时为10.95。阻塞性和中枢性呼吸事件均导致了AHI的差异。与L-PSG相比,H-PSG时的氧合和睡眠碎片化情况更差,脉搏率更高。
这些发现揭示了海拔高度对居住在高海拔地区的SDB儿童的呼吸、睡眠和心血管结果具有临床上的显著影响。在这一人群中,与H-PSG相比,L-PSG低估了阻塞性睡眠呼吸暂停和中枢性睡眠呼吸暂停。鉴于高海拔儿科睡眠实验室的短缺,这些结果表明家庭睡眠呼吸暂停测试对居住在高海拔地区的儿童具有作用。